Elusys Therapeutics, Inc.
about us Elusys & Biodefense product news&events careers
Elusys Overview Leadership
Executive Team Board of  Directors
Anthrax & Bioterrorism Contract Experience Useful Links
Anthim Anthrax Antibody Anthim Publication
Press Releases Presentations
Our Values Working at Elusys Open Positions Benefits Location

NEWS & EVENTS

PRESS RELEASES 2004

2011   2010   2009   2008   2007   2006   2005   2004

 

November 1, 2004


Elusys Therapeutics Presents Staphylococcus Aureus Data at iCAAC

 

October 13, 2004

 

 

Elusys Therapeutics Receives Broad Government Funding to Continue Development of Anti-Anthrax Drug

 

August 2, 2004

Elusys Therapeutics Completes Round of Private Financing

 

July 23, 2004

 

Elusys Therapeutics Announces Reorganization

 

May 5, 2004

 

Elusys Therapeutics Anthrax Product Selected for Testing by Federal Government

 

March 8, 2004

 

Elusys Presents Data on Anthrax Antibody at American Society for Microbiology’s Biodefense Research Meeting

 

February 20, 2004

 

 

Elusys Therapeutics to Present at Bio CEO and Investor Conference

 

 

 

 

 

 

 

 

  • Copyright© 2012 Elusys Therapeutics, Inc. All Rights Reserved.
  • contact us
  • site map
  • careers